Targeting Protein Tyrosine Phosphatase 22 Does Not Enhance the Efficacy of Chimeric Antigen Receptor T Cells in Solid Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Protein Tyrosine Phosphatase 22 Does Not Enhance the Efficacy of Chimeric Antigen Receptor T Cells in Solid Tumors

Published:2022-03-01 Issue:3 Volume:42 Page:
ISSN:1098-5549
Container-title:Molecular and Cellular Biology
language:en
Short-container-title:Molecular and Cellular Biology

Author:

Du Xin¹²,Darcy Phillip K.¹²,Wiede Florian¹³⁴,Tiganis Tony¹³⁴^ORCID

Affiliation:

1. Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

2. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia

3. Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia

4. Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia

Funder

Department of Health | National Health and Medical Research Council

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology

Link

https://journals.asm.org/doi/pdf/10.1128/mcb.00449-21

Reference66 articles.

1. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

2. Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity

3. Cancer immunotherapy using checkpoint blockade

4. The blockade of immune checkpoints in cancer immunotherapy

5. Engineered T cells: the promise and challenges of cancer immunotherapy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of T Cell Signaling and Immune Responses by PTPN22;Molecular and Cellular Biology;2024-07-22

2. Targeting Protein Tyrosine Phosphatases to Improve Cancer Immunotherapies;Cells;2024-01-25

3. Protein tyrosine phosphatases as emerging targets for cancer immunotherapy;British Journal of Pharmacology;2024-01-17

4. Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion;Journal for ImmunoTherapy of Cancer;2023-12

5. Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status;Frontiers in Immunology;2023-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3